左卡尼汀预防紫杉醇周围神经毒性的临床观察

严建维

doi:10.3969/j.issn.1006-0111.2014.05.016

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

左卡尼汀预防紫杉醇周围神经毒性的临床观察

严建维

文章导航 > 药学实践与服务 > 2014 > 32(5): 372-373

严建维. 左卡尼汀预防紫杉醇周围神经毒性的临床观察[J]. 药学实践与服务, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016

引用本文:

严建维. 左卡尼汀预防紫杉醇周围神经毒性的临床观察[J]. 药学实践与服务, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016

YAN Jianwei. Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016

Citation:

YAN Jianwei. Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(5): 372-373. doi: 10.3969/j.issn.1006-0111.2014.05.016

左卡尼汀预防紫杉醇周围神经毒性的临床观察

doi: 10.3969/j.issn.1006-0111.2014.05.016

严建维

余姚市人民医院内科, 浙江余姚 315400

Clinical observation of levocarnitine in prevention from peripheral nerve toxicity caused by paclitaxel

YAN Jianwei

Department of Medicine, Yuyao People's Hospital, Yuyao 315400, China

摘要: 目的观察左卡尼汀预防紫杉醇引起的周围神经毒性作用。方法将 64例接受紫杉醇化疗的肿瘤患者随机分为两组,预防性治疗组患者在应用紫杉醇化疗同时给予左卡尼汀治疗,对照组化疗方案与前组相同但未接受左卡尼汀预防性治疗。分别比较两组患者的周围神经毒性发生率。结果预防性治疗组周围神经毒性发生率低于对照组,差异有统计学意义(P<0.05)。结论应用紫杉醇联合化疗中预防性给予左卡尼汀,可减少化疗相关的周围神经毒性。
- 左卡尼汀 /
- 紫杉醇 /
- 神经毒性
Abstract: Objective To observe levocarnitine in prevention and treatment of peripheral nerve toxicity caused by paclitaxel. Methods 64 cancer patients treated with paclitaxel-based chemotherapy were randomly divided into two groups, the preventive treatment group and control group.The patients in the preventive treatment group were treated with paclitaxel chemotherapy and levocarnitine.The patients in the control group were treated with the same chemotherapy but without levocarnitine.The incidence rate of neurotoxicity between two groups were compared. Results The incidence rate of neurotoxicity in the preventive treatment group was lower than that of the control group(P<0.05). Conclusion Application of levocarnitine in paclitaxel-based chemotherapy could reduce the neurotoxicity caused by chemotherapy.
- levocarnitine /
- paclitaxel /
- neurotoxicity

[1]	Ghirardi O,Lo Giudice P,Pisano C,et al.Acetyl-L-carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin,without altering its antitumor properties[J].Anticancer Res,2005,25(4):2681-2687.
[2]	Gunes D, Kirkim G, Kolatan E,et al. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity[J].Chemotherapy,2011,57(3):186-194.
[3]	孙燕.抗癌药物急性与亚急性毒性反应分度标准临床肿瘤手册[M].5版.北京:人民卫生出版社,2005:145.
[4]	Xiao WH, Zheng H, Zheng FY,et al. Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat[J].Neuroscience,2011,199:461-469.
[5]	He MD, Xu SC, Lu YH,et al.L-carnitine protects against nickel-induced neurotoxicity by maintaining mitochondrial function in neuro-2a cells[J].Toxicol Appl Pharmacol,2011,253(1):38-44.
[6]	Nagesh BG, Kumar A, Singh RL.Chronic pretreatment with acetyl-L-carnitine and ±DL-α-lipoic acid protects against acute glutamate-induced neurotoxicity in rat brain by altering mitochondrial function[J].Neurotox Res,2011,19(2):319-329.
[7]	Zheng H, Xiao WH, Bennett GJ. Functional deficits in peripheral nerve mitochondria in rats with paclitaxel-and oxaliplatin-evoked painfulperipheral neuropathy[J]. Exp Neurol,2011,232(2):154-161.

[1]	陈炳辰, 于恩达. 增强紫杉醇对结直肠癌化疗疗效的研究进展 . 药学实践与服务, 2020, 38(6): 501-505. doi: 10.12206/j.issn.1006-0111.202007031
[2]	林莉莉, 黄爱文, 林美钦, 方婕, 沈钦勇, 宋洪涛. 替吉奥单药或联合铂类治疗晚期非小细胞肺癌患者疗效与安全性的Meta评价 . 药学实践与服务, 2019, 37(6): 563-570. doi: 10.3969/j.issn.1006-0111.2019.06.018
[3]	程丹, 许幼发, 傅志勤, 陈建明. 靶向肿瘤微环境的紫杉醇前药研究进展 . 药学实践与服务, 2018, 36(1): 1-8. doi: 10.3969/j.issn.1006-0111.2018.01.001
[4]	程丹, 陈建明. 反相高效液相色谱法同时测定大鼠血浆中紫杉醇硬脂酸酯及其活性代谢产物紫杉醇的含量 . 药学实践与服务, 2018, 36(3): 224-227,273. doi: 10.3969/j.issn.1006-0111.2018.03.007
[5]	杨姣, 陈君君, 张湘奇, 张婧娴, 韩永龙. 消癌平注射液联合紫杉醇对人卵巢癌SK-OV-3细胞增殖及裸鼠异位移植瘤生长的作用 . 药学实践与服务, 2017, 35(6): 516-519,529. doi: 10.3969/j.issn.1006-0111.2017.06.009
[6]	张琦, 赵文萃, 刘洋, 张公良, 成念, 侯吉华. 疏水改性白及多糖自组装载紫杉醇纳米粒子在大鼠体内药动学研究 . 药学实践与服务, 2017, 35(6): 504-507. doi: 10.3969/j.issn.1006-0111.2017.06.006
[7]	成念, 赵文萃, 张琦, 王艳萍, 韩丹, 肖轩昂. 用疏水改性的白及多糖制备载紫杉醇纳米粒并对其表征 . 药学实践与服务, 2017, 35(1): 48-53. doi: 10.3969/j.issn.1006-0111.2017.01.012
[8]	谢昊霖, 陈虹, 章斌, 田泾. 左卡尼汀致癫痫发作合并房颤、白细胞异常升高1例 . 药学实践与服务, 2017, 35(2): 191-192. doi: 10.3969/j.issn.1006-0111.2017.02.025
[9]	田逸君, 郑怡文, 朱玉平, 张晓芳, 宗英, 陆国才. 雷公藤内酯醇的遗传毒性评价 . 药学实践与服务, 2016, 34(3): 215-218. doi: 10.3969/j.issn.1006-0111.2016.03.006
[10]	俞卉, 杨宏, 万方辉, 韩雪敏, 王道灵, 赵晓红. 右美托咪啶对左布比卡因锁骨上臂丛神经阻滞时效的影响 . 药学实践与服务, 2016, 34(5): 412-415. doi: 10.3969/j.issn.1006-0111.2016.05.008
[11]	王可兴, 秦翠英, 韩静, 李荣丽, 陈仁财. 紫杉醇自微乳滴丸的制备及体外释放考察 . 药学实践与服务, 2016, 34(4): 330-333. doi: 10.3969/j.issn.1006-0111.2016.04.012
[12]	王欢, 佘岚, 王琳召, 马志强, 张欣荣, 杨峰. 氧化介孔碳球纳米粒作为紫杉醇载体的研究 . 药学实践与服务, 2015, 33(2): 114-118. doi: 10.3969/j.issn.1006-0111.2015.02.005
[13]	纪松岗, 吴琼, 朱臻宇, 董昕, 洪战英, 柴逸峰. 左卡尼汀缓解顺铂造成急性肾损伤的血清代谢组学研究 . 药学实践与服务, 2015, 33(5): 429-433. doi: 10.3969/j.issn.1006-0111.2015.05.012
[14]	孙德好, 邵凌, 刘胜, 陈森林, 曹晓冰. 依立替康/氟尿嘧啶/亚叶酸三药联用治疗晚期胃癌的临床疗效观察 . 药学实践与服务, 2009, 27(3): 189-192.
[15]	丁如贤, 王昊, 许铁峰, 张汉明. 红豆杉的生物工程研究进展 . 药学实践与服务, 2000, (5): 274-276.
[16]	胡玲琼, 王安军, 唐凡. 青霉素的神经毒性反应及合理应用 . 药学实践与服务, 1999, (5): 308-309.
[17]	张清林, 王爱平. 紫杉醇对大鼠的一般生殖毒性作用 . 药学实践与服务, 1996, (4): 199-201.
[18]	朱全刚, 魏水易. 抗肿瘤新药紫杉醇 . 药学实践与服务, 1995, (1): 12-14.
[19]	Sashishukla. 锂—卡马四平神经毒性及危险因素 . 药学实践与服务, 1985, (4): 23-24.
[20]	苟奎斌, 张紫洞. 干扰素对中枢神经系统的毒性 . 药学实践与服务, 1984, (3): 60-60.

点击查看大图

计量

文章访问数: 1904
HTML全文浏览量: 198
PDF下载量: 167
被引次数: 0

左卡尼汀预防紫杉醇周围神经毒性的临床观察

doi: 10.3969/j.issn.1006-0111.2014.05.016

严建维

余姚市人民医院内科, 浙江余姚 315400

收稿日期: 2013-04-01
修回日期: 2013-07-30

关键词:

左卡尼汀 /

紫杉醇 /

神经毒性

摘要: 目的观察左卡尼汀预防紫杉醇引起的周围神经毒性作用。方法将 64例接受紫杉醇化疗的肿瘤患者随机分为两组,预防性治疗组患者在应用紫杉醇化疗同时给予左卡尼汀治疗,对照组化疗方案与前组相同但未接受左卡尼汀预防性治疗。分别比较两组患者的周围神经毒性发生率。结果预防性治疗组周围神经毒性发生率低于对照组,差异有统计学意义(P<0.05)。结论应用紫杉醇联合化疗中预防性给予左卡尼汀,可减少化疗相关的周围神经毒性。